NK cells specifically TCR-dressed to kill cancer cells
Nadia Mensali(Oslo University Hospital), Sébastien Wälchli(Oslo University Hospital)
Cited by 77
Related Papers
A TCR-based Chimeric Antigen Receptor
|Scientific Reports|2017|90
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
|Cell Reports Medicine|2024|18
382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma
|Regular and Young Investigator Award Abstracts|2021|0